查看購物車
  • Simplified Chinese
  • English
中東和非洲 PCR 技術市場預測至 2030 年 - 區域分析 - 按技術、產品、應用和最終用戶
市場調查報告書
商品編碼
1562192

中東和非洲 PCR 技術市場預測至 2030 年 - 區域分析 - 按技術、產品、應用和最終用戶

Middle East & Africa PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 131 Pages | 訂單完成後即時交付

價格

中東和非洲PCR技術市場預計將從2022年的6.2635億美元成長到2030年的10.5727億美元。

遺傳性疾病和傳染病發病率的上升推動了中東和非洲 PCR 技術市場

根據國家組織關於遺傳性疾病或先天性殘疾的資訊，遺傳性疾病是一種罕見疾病，但每年總共有超過 15,500 例陽性診斷。美國 MJH 生命科學公司 2022 年發布的報告估計，全球每年約有 30 萬名新生兒出生時患有鐮狀細胞疾病 (SCD)，約佔全球人口的 5%。此外，根據諾華公司 2020 年 6 月的報告，SCD 影響全球約 800 萬人。在非洲，每天約有 500 名兒童死於與 SCD 相關的併發症，該疾病的負擔最重。由於 SCD 發病率不斷上升，病理中心擴大採用數位聚合酶鍊式反應 (dPCR)，其中該技術被用於針對各種 DNA 特異性序列來確認診斷並設計各種臨床測試。 dPCR 可以只針對一個 DNA 分子中的特定 DNA 序列。該工具使研究人員能夠檢測使用即時 PCR 難以識別的罕見基因突變。 COVID-19 的爆發對 PCR 技術市場產生了重大影響。 PCR 是一種幾乎無所不在、強大且可靠的技術，大多數分子生物學實驗室都使用它來擴增特定的 DNA 片段，以進行基因分型、克隆和單核苷酸變異分析。擴增的 DNA 甚至可以作為大多數下一代定序 (NGS) 製備的基礎。幾乎所有診斷測試都使用即時 PCR 來測試有 COVID-19 症狀的人。大多數生物技術和製藥企業將重點轉向研發 (R&D) 部門，尋找針對 COVID-19 的新化合物或治療方法，這反過來又使 PCR 技術市場受益。 2022年2月，羅氏將新發表的分子實驗室儀器Cobas 5800系統加入其COVID-19 PCR產品組合中，供接受CE認證的國家使用。這些產品包括 Cobas SARS-CoV-2 和甲型/乙型流感檢測，以及 Cobas SARS-CoV-2 定性檢測。本產品在低、中、高容量分子實驗室測試中提供一致的性能和效率。因此，遺傳性疾病和傳染病發病率的增加支持了 PCR 技術市場的成長。

中東和非洲 PCR 技術市場概況

中東和非洲 PCR 技術市場分為沙烏地阿拉伯、阿拉伯聯合大公國、南非以及中東和非洲其他地區。由於該地區各種試劑系統和自動化系統的開發增加、診斷實驗室的各種新產品以及越來越多的會議、會議、工作坊和專題討論會，預計該地區將出現顯著成長。沙烏地阿拉伯是中東和非洲成長最快的國家之一。透過政府和國際參與者之間的公私合作夥伴關係改變醫療保健基礎設施可以加強該國的醫療保健部門。這些夥伴關係和私有化努力與沙烏地阿拉伯政府轉型國家經濟的「2030 年願景」政策一致。根據國際貿易管理局的數據，作為 2030 年願景的一部分，沙烏地阿拉伯政府投資約 650 億美元來建設該國的醫療保健基礎設施。 PCR技術在傳染病、腫瘤學、自體免疫疾病、遺傳疾病、愛滋病毒/愛滋病等診斷方面有著廣泛的應用。它由醫院、實驗室和其他醫療機構的醫生以及患者治療過程的各個階段使用。此外，DNA 多態性、肺癌和大腸癌的研究使用 dPCR 和 qPCR 技術來評估基因的 mRNA 表達，推動了 PCR 技術市場的發展。沙烏地阿拉伯由於近親結婚導致遺傳疾病數量不斷增加，婚前基因篩檢的增加推動了市場的成長。沙烏地阿拉伯政府強制要求婚前進行婚前基因篩檢，以檢查基因相容性，以減少該國最受歡迎的遺傳性血液疾病，如鐮狀細胞疾病和BETA地中海貧血。因此，沙烏地阿拉伯遺傳病患病率的上升和婚前基因檢測的增加推動了市場的成長。此外，不斷成長的癌症病例也推動了沙烏地阿拉伯的癌症研究。根據 Globocan 2020資料，該國記錄了約 27,885 例新癌症病例。研究發現，所有年齡層的癌症五年盛行率為每 10 萬人 237.4 人，這反過來又推動了沙烏地阿拉伯對 PCR 技術的需求。

中東和非洲 PCR 技術市場收入及 2030 年預測（百萬美元）

中東和非洲 PCR 技術市場細分

中東和非洲 PCR 技術市場分為技術、產品、應用、最終用戶和國家。

根據技術，中東和非洲 PCR 技術市場分為即時 PCR、常規 PCR、逆轉錄、數位 PCR、多重 RTPCR、熱啟動 PCR 等。 2022 年，即時 PCR 領域在中東和非洲 PCR 技術市場中佔據最大佔有率。

在產品方面，中東和非洲 PCR 技術市場分為試劑和耗材、儀器以及軟體和服務。到2022年，試劑和耗材細分市場在中東和非洲PCR技術市場中佔據最大佔有率。此外，西林瓶尺寸分為0.2ml至2ml、0.1ml至0.3ml、2ml至5ml等西林瓶。此外，儀器部分分為桌上型 PCR 和攜帶式熱循環儀/PCR。

根據應用，中東和非洲 PCR 技術市場分為基因表現分析、基因定序、基因分型、核酸合成、標準驗證、照護端診斷應用、環境應用等。 2022 年，基因表現分析領域在中東和非洲 PCR 技術市場中佔據最大佔有率。

根據最終用戶，中東和非洲 PCR 技術市場分為醫院和診斷中心、製藥和生物技術公司、學術機構和研究實驗室等。 2022 年，醫院和診斷中心細分市場在中東和非洲 PCR 技術市場中佔據最大佔有率。

按國家/地區分類，中東和非洲 PCR 技術市場分為沙烏地阿拉伯、南非、阿拉伯聯合大公國以及中東和非洲其他地區。 2022 年，沙烏地阿拉伯將主導中東和非洲 PCR 技術市場。

Thermo Fisher Scientific Inc、Promega Corp、QIAGEN NV、bioMerieux SA、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Becton Dickinson and Co、Takara Bio Inc、Standard Bio Tools Inc 和 Ellume Ltd 是一些領先的營運公司中東和非洲PCR 技術市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：中東和非洲 PCR 技術市場 - 主要產業動態

  • PCR 技術市場 - 主要產業動態
  • 市場促進因素
    • 遺傳性疾病和傳染病的盛行率不斷上升
  • 市場限制
    • PCR 系統的高成本和替代檢測的可用性
  • 市場機會
    • 新興國家擴大採用 PCR 技術
    • POC 測試需求不斷增加
  • 未來趨勢
    • PCR 技術的進步
  • 促進因素和限制的影響：

第 5 章：PCR 技術市場 - 中東和非洲市場分析

  • PCR 技術市場收入，2020 - 2030

第 6 章：中東和非洲 PCR 技術市場分析 - 按技術

  • 概述
  • 即時螢光定量PCR
  • 常規PCR
  • 逆轉錄聚合酶連鎖反應
  • 數位PCR
  • 多重逆轉錄聚合酶連鎖反應
  • 熱啟動PCR
  • 其他

第 7 章：中東和非洲 PCR 技術市場分析 - 按產品

  • 概述
  • 2022 年和 2030 年 PCR 技術市場收入佔有率（按產品分類）（%）
  • 試劑及耗材
  • 儀器儀表
  • 軟體和服務

第 8 章：中東和非洲 PCR 技術市場分析 - 按應用

  • 概述
  • 2022 年和 2030 年 PCR 技術市場收入佔有率，按應用分類 (%)
  • 基因表現分析
  • 基因定序
  • 基因分型
  • 核酸合成
  • 標準驗證
  • 照護端診斷
  • 環境應用
  • 其他

第 9 章：中東和非洲 PCR 技術市場分析 - 按最終用戶

  • 概述
  • 2022 年和 2030 年 PCR 技術市場收入佔有率（按最終用戶分類）（%）
  • 醫院和診斷中心
  • 學術界及研究機構
  • 製藥和生物技術公司
  • 其他

第 10 章：中東和非洲 PCR 技術市場 - 國家分析

  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 11 章：PCR 技術市場-產業格局

  • 概述
  • PCR 技術市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • QIAGEN NV
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Becton Dickinson and Co
  • Takara Bio Inc
  • Standard Biotools Inc
  • Ellume Ltd

第 13 章：附錄

Product Code: BMIRE00030470

The Middle East & Africa PCR technologies market is expected to grow from US$ 626.35 million in 2022 to US$ 1,057.27 million by 2030. It is estimated to record a CAGR of 6.8% from 2022 to 2030.

Rising Prevalence of Genetic and Infectious Diseases Bolsters Middle East & Africa PCR Technologies Market

According to the National Organization's information on genetic conditions or congenital disabilities, genetic disorders are rare conditions, but they collectively comprise over 15,500 positive diagnoses every year. Estimates published in a report by MJH Life Sciences (US) in 2022 state that ~300,000 newborns are born with sickle cell disease (SCD) globally every year, accounting for ~5% of the global population. Further, as per the June 2020 report by Novartis AG, SCD affects around eight million individuals globally. Around 500 children die from SCD-related complications per day in Africa, where the disease has the highest burden. As a result of the rising incidence of SCDs, the adoption of digital polymerase chain reaction (dPCR) is increasing in pathology centers, wherein this technology is being exploited for targeting various DNA-specific sequences to confirm diagnoses and design various clinical tests. dPCR can target specific DNA sequences in just one molecule of DNA. This tool allows researchers to detect rare genetic mutations that are difficult to identify by using real-time PCR. The COVID-19 outbreak had a significant impact on the PCR technologies market. PCR is a nearly ubiquitous, robust, and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and analysis of single nucleotide variations. The amplified DNA even serves as the basis for most next-generation sequencing (NGS) preparation. Nearly all diagnostic tests used real-time PCR for testing people having symptoms of COVID-19. Most of the biotech and pharmaceutical businesses shifted their focus toward research and development (R&D) divisions to find novel compounds or therapeutic approaches for COVID-19, which, in turn, benefitted the PCR technologies market. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These products include the Cobas SARS-CoV-2 and influenza A/B tests, as well as the Cobas SARS-CoV-2 qualitative test. The product offers uniform performance and efficiency in low-, medium-, and high-volume molecular laboratory tests. Thus, the increasing incidence of genetic and infectious diseases supports the growth of the PCR technologies market.

Middle East & Africa PCR Technologies Market Overview

The Middle East & Africa PCR technologies market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa. The region is expected to experience significant growth due to an increase in the development of varied reagent systems and automated systems in this region, a wide range of new products in diagnostic laboratories, and a growing number of conferences, meetings, workshops, and symposiums. Saudi Arabia is among the fastest-growing countries in the Middle East & Africa. Changing healthcare infrastructure through public-private partnerships between government and international players strengthens the country's healthcare sector. These partnerships and privatization efforts align with the Saudi government's "Vision 2030" policies to transform the national economy. As per the International Trade Administration, the Saudi Arabian government invested ~US$ 65 billion to build the country's healthcare infrastructure as part of Vision 2030. Increased investment in infrastructure and innovation is anticipated to favor the market positively. PCR technologies have wide applications in the diagnosis of infectious diseases, oncology, autoimmune diseases, genetic diseases, HIV/AIDS, and others. It is used by medical practitioners in hospitals, laboratories, and other healthcare facilities and at various stages of the patient treatment process. Further, studies on DNA polymorphism, lung cancer, and colorectal cancer use dPCR and qPCR techniques to assess the mRNA expression of genes, boosting the PCR technologies market. Saudi Arabia has a growing number of genetic diseases due to consanguineous marriage, and thus, the increase in premarital genetic screening drives the market growth. The Government of Saudi Arabia has made it mandatory to undergo premarital genetic screening before marriage to check genetic compatibility to reduce hereditary blood diseases such as sickle cell and beta-thalassemia, which are most prevalent in the country. Therefore, the rising prevalence of genetic diseases and increasing premarital genetic testing in Saudi Arabia drive the market growth. Also, the growing number of cancer cases has fueled cancer research in Saudi Arabia. As per Globocan 2020 data, the country recorded ~27,885 new cancer cases. The five-year prevalence rate for cancer in all ages was found to be 237.4 per 100,000 people, which, in turn, propels the demand for PCR technologies in Saudi Arabia.

Middle East & Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa PCR Technologies Market Segmentation

The Middle East & Africa PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the Middle East & Africa PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of Middle East & Africa PCR technologies market in 2022.

In terms of offerings, the Middle East & Africa PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Middle East & Africa PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

Based on application, the Middle East & Africa PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Middle East & Africa PCR technologies market in 2022.

Based on end user, the Middle East & Africa PCR technologies market is segmented into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of Middle East & Africa PCR technologies market in 2022.

By country, the Middle East & Africa PCR technologies market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, and Ellume Ltd are some of the leading companies operating in the Middle East & Africa PCR technologies market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Middle East & Africa PCR Technologies Market - Key Industry Dynamics

  • 4.1 PCR Technologies Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
    • 4.4.2 Increasing Demand for POC Testing
  • 4.5 Future Trends
    • 4.5.1 Advancements in PCR Technologies
  • 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - Middle East & Africa Market Analysis

  • 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. Middle East & Africa PCR Technologies Market Analysis - By Technology

  • 6.1 Overview
  • 6.2 Real Time PCR
    • 6.2.1 Overview
    • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Conventional PCR
    • 6.3.1 Overview
    • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Reverse Transcription PCR
    • 6.4.1 Overview
    • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Digital PCR
    • 6.5.1 Overview
    • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Multiplex RT PCR
    • 6.6.1 Overview
    • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hot Start PCR
    • 6.7.1 Overview
    • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa PCR Technologies Market Analysis - By Offerings

  • 7.1 Overview
  • 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
  • 7.3 Reagents and Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
        • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • 7.5 Software and Services
    • 7.5.1 Overview
    • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa PCR Technologies Market Analysis - By Application

  • 8.1 Overview
  • 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Gene Expression Analysis
    • 8.3.1 Overview
    • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Genetic Sequencing
    • 8.4.1 Overview
    • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genotyping
    • 8.5.1 Overview
    • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Nucleic Acid Synthesis
    • 8.6.1 Overview
    • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Standard Validation
    • 8.7.1 Overview
    • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Point of Care Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Environmental Application
    • 8.9.1 Overview
    • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa PCR Technologies Market Analysis - By End User

  • 9.1 Overview
  • 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Academia and Research Institutes
    • 9.4.1 Overview
    • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pharmaceutical and Biotechnology Companies
    • 9.5.1 Overview
    • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa PCR Technologies Market -Country Analysis

  • 10.1 Middle East & Africa: PCR Technologies Market
    • 10.1.1 Overview
    • 10.1.2 Middle East & Africa PCR Technologies Market Revenue and Forecast and Analysis - By Country
      • 10.1.2.1 Saudi Arabia
        • 10.1.2.1.1 Overview
      • 10.1.2.2 Saudi Arabia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Technology
        • 10.1.2.2.2 Saudi Arabia PCR Technologies Market Breakdown by Offerings
        • 10.1.2.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Instruments
        • 10.1.2.2.2.2 Saudi Arabia PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.2.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.2.3 Saudi Arabia PCR Technologies Market Breakdown by Application
        • 10.1.2.2.4 Saudi Arabia PCR Technologies Market Breakdown by End User
      • 10.1.2.3 South Africa
        • 10.1.2.3.1 Overview
      • 10.1.2.4 South Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.1 South Africa PCR Technologies Market Breakdown by Technology
        • 10.1.2.4.2 South Africa PCR Technologies Market Breakdown by Offerings
        • 10.1.2.4.2.1 South Africa PCR Technologies Market Breakdown by Instruments
        • 10.1.2.4.2.2 South Africa PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.4.2.2.1 South Africa PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.4.3 South Africa PCR Technologies Market Breakdown by Application
        • 10.1.2.4.4 South Africa PCR Technologies Market Breakdown by End User
      • 10.1.2.5 United Arab Emirates
        • 10.1.2.5.1 Overview
      • 10.1.2.6 United Arab
        • 10.1.2.6.1 United Arab Emirates PCR Technologies Market Breakdown by Technology
        • 10.1.2.6.2 United Arab Emirates PCR Technologies Market Breakdown by Offerings
        • 10.1.2.6.2.1 United Arab Emirates PCR Technologies Market Breakdown by Instruments
        • 10.1.2.6.2.2 United Arab Emirates PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.6.2.2.1 United Arab Emirates PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.6.3 United Arab Emirates PCR Technologies Market Breakdown by Application
        • 10.1.2.6.4 United Arab Emirates PCR Technologies Market Breakdown by End User
      • 10.1.2.7 Rest of Middle East & Africa
        • 10.1.2.7.1 Overview
      • 10.1.2.8 Rest of Middle East & Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.8.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Technology
        • 10.1.2.8.2 Rest of Middle East & Africa PCR Technologies Market Breakdown by Offerings
        • 10.1.2.8.2.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Instruments
        • 10.1.2.8.2.2 Rest of Middle East & Africa PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.8.2.2.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.8.3 Rest of Middle East & Africa PCR Technologies Market Breakdown by Application
        • 10.1.2.8.4 Rest of Middle East & Africa PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the PCR Technologies Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 QIAGEN NV
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 bioMerieux SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hoffmann-La Roche Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bio-Rad Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Takara Bio Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Standard Biotools Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Ellume Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. PCR Technologies Market Segmentation
  • Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
  • Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
  • Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
  • Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
  • Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
  • Table 9. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 10. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 11. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 12. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 13. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 14. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 15. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 16. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 17. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 18. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 19. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 20. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 21. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 22. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 23. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 24. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 25. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 26. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 27. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 28. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 29. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 30. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 31. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 32. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 33. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 34. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 35. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 36. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 37. Recent Inorganic Growth Strategies in the PCR Technologies Market
  • Table 38. Recent Organic Growth Strategies in the PCR Technologies Market
  • Table 39. Glossary of Terms, PCR Technologies Market

List Of Figures

  • Figure 1. PCR Technologies Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
  • Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
  • Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
  • Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
  • Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. Middle East & Africa: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Middle East & Africa PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 32. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 36. Growth Strategies in the PCR Technologies Market